Infigratinib shows promising efficacy and tolerability in pediatric achondroplasia
1. In this phase two dose-finding study in children with achondroplasia, daily oral Infigratinib did not lead to any grade ...
1. In this phase two dose-finding study in children with achondroplasia, daily oral Infigratinib did not lead to any grade ...
2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.